Recruitment

Eingeschlossene Patienten: 23.947 (Stand 02. Februar 2026)
Amgevita® (Adalimumab)276
Benepali® (Etanercept)1323
Cimzia® (Certolizumab)1066
Enbrel® (Etanercept)2881
Erelzi® (Etanercept)639
Flixabi® (Infliximab)10
Hukyndra® (Adalimumab)23
Hulio® (Adalimumab)322
Humira® (Adalimumab)2912
Hyrimoz® (Adalimumab)297
Idacio® (Adalimumab)76
Imraldi® (Adalimumab)258
Inflectra™ (Infliximab)16
Jyseleca® (Filgotinib)199
Kevzara® (Sarilumab)248
Kineret® (Anakinra)89
MabThera® (Rituximab)1459
Nepexto® (Etanercept)119
Olumiant® (Baricitinib)566
Orencia® (Abatacept)1001
Remicade® (Infliximab)762
Remsima® (Infliximab)27
Rinvoq® (Upadacitinib)370
Rixathon® (Rituximab)20
RoActemra® (Tocilizumab)1383
Ruxience® (Rituximab)1
Simponi® (Golimumab)486
Truxima® (Rituximab)9
Tyenne® (Tocilizumab)76
Xeljanz® (Tofacitinib)404
Yuflyma® (Adalimumab)83
Zessly® (Infliximab)2
Kontrollen6544